Cytek Biosciences, Inc 10-Q for FY2022 Q1
Cytek Biosciences, Inc. (CTKB)
10-Q
2022-05-12
For: 2022-03-31
View Original
Added on
April 09, 2026
About this 10-Q
Cytek Biosciences, Inc filed this 10-Q on May 12, 2022, covering the quarter ended March 31, 2022 (FY2022 Q1).
Headline figures
Quarter ended March 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $35.06M
- up 44.5% from $24.27M a year earlier
- Net loss
- $2.16M
- compared with net income of $102K a year earlier
- Diluted EPS
- $0.02
- compared with $0.00 a year earlier